UNLABELLED: Renal dysfunction prior to liver transplantation has a marked impact on post-transplant kidney outcomes. AIM: The aim of this study was to assess post-transplant renal function in patients with chronic kidney disease (CKD) receiving orthotopic liver transplantation (OLT) alone. METHODS: Retrospective review of 40 OLT recipients with pre-transplant CKD (serum creatinine ≥2 mg/dL for at least three months) at the University of Pennsylvania from February 2002 to July 2010. Primary outcome was estimated glomerular filtration rate (eGFR) up to three years post-transplant. Secondary outcomes included incidence of stage 4 CKD (eGFR < 30 mL/min), need for renal replacement therapy (RRT), meeting criteria for kidney transplant listing (eGFR ≤ 20 mL/min), and mortality. RESULTS: Median patient age was 56.5 yr and 48% patients had pre-transplant diabetes. Median serum creatinine at transplant was 2.7 mg/dL (eGFR = 24 mL/min). Median eGFR at one, two, and three yr post-transplant was 35, 34, and 37 mL/min, respectively. Twelve patients (30%) required RRT at a median of 1.21 yr post-transplant and 16 (40%) achieved an eGFR ≤ 20 mL/min at 1.09 yr post-transplant. Mortality was 35% at a median of 1.60 years post-transplant. CONCLUSIONS: OLT recipients with pre-transplant CKD have a substantial burden of post-transplant renal dysfunction and high short-term mortality, questioning the rationale for OLT alone in this population.
UNLABELLED: Renal dysfunction prior to liver transplantation has a marked impact on post-transplant kidney outcomes. AIM: The aim of this study was to assess post-transplant renal function in patients with chronic kidney disease (CKD) receiving orthotopic liver transplantation (OLT) alone. METHODS: Retrospective review of 40 OLT recipients with pre-transplant CKD (serum creatinine ≥2 mg/dL for at least three months) at the University of Pennsylvania from February 2002 to July 2010. Primary outcome was estimated glomerular filtration rate (eGFR) up to three years post-transplant. Secondary outcomes included incidence of stage 4 CKD (eGFR < 30 mL/min), need for renal replacement therapy (RRT), meeting criteria for kidney transplant listing (eGFR ≤ 20 mL/min), and mortality. RESULTS: Median patient age was 56.5 yr and 48% patients had pre-transplant diabetes. Median serum creatinine at transplant was 2.7 mg/dL (eGFR = 24 mL/min). Median eGFR at one, two, and three yr post-transplant was 35, 34, and 37 mL/min, respectively. Twelve patients (30%) required RRT at a median of 1.21 yr post-transplant and 16 (40%) achieved an eGFR ≤ 20 mL/min at 1.09 yr post-transplant. Mortality was 35% at a median of 1.60 years post-transplant. CONCLUSIONS: OLT recipients with pre-transplant CKD have a substantial burden of post-transplant renal dysfunction and high short-term mortality, questioning the rationale for OLT alone in this population.
Authors: Thomas A Gonwa; Linda Jennings; Martin L Mai; Paul C Stark; Andrew S Levey; Goran B Klintmalm Journal: Liver Transpl Date: 2004-02 Impact factor: 5.799
Authors: J F Markmann; J W Markmann; D A Markmann; A Bacquerizo; J Singer; C D Holt; J Gornbein; H Yersiz; M Morrissey; S M Lerner; S V McDiarmid; R W Busuttil Journal: Transplantation Date: 2001-09-27 Impact factor: 4.939
Authors: R Ruebner; D Goldberg; P L Abt; R Bahirwani; M Levine; D Sawinski; R D Bloom; P P Reese Journal: Am J Transplant Date: 2012-07-03 Impact factor: 8.086
Authors: C L Davis; S Feng; R Sung; F Wong; N P Goodrich; L B Melton; K R Reddy; M K Guidinger; A Wilkinson; J Lake Journal: Am J Transplant Date: 2007-05-26 Impact factor: 8.086
Authors: Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion Journal: N Engl J Med Date: 2003-09-04 Impact factor: 91.245
Authors: Yücel Yankol; Emily Bugeaud; Tiffany Zens; Michael Rizzari; Nesimi Mecit; Glen E Leverson; David Foley; Joshua D Mezrich; Turan Kanmaz; Oya Münevver Andaçoğlu; Anthony M D'Alessandro; Koray Sadık Acarlı; Münci Kalayoğlu; Luis A Fernandez Journal: Turk J Med Sci Date: 2021-04-30 Impact factor: 0.973